Acumen Pharmaceuticals Inc share price logo

Acumen Pharmaceuticals Inc

NASDAQ: ABOS

Small Cap

$2.53

+0.05

(+2.02%)

as on

Acumen Pharmaceuticals Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.47
    $2.55
    downward going graph

    2.37%

    Downside

    0.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.96
    $3.60
    downward going graph

    62.11%

    Downside

    42.29%

    Upside

    downward going graph

Acumen Pharmaceuticals Inc share price movements today

Previous Close
$2.48
Open
$2.50
Volume
472.6K
Day's Low - High
$2.47 - $2.55
52 Week Low - High
$0.96 - $3.60

Acumen Pharmaceuticals Inc Historical Returns

1 Month Return
-10.14 %
3 Month Return
+ 3.33 %
1 Year Return
+ 148 %
3 Year Return
-53.12 %
5 Year Return
0 %

Acumen Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Acumen Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$171.9M

EPS (TTM)

-1.883

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-123.8M

Revenue (TTM)

329.0K

Profit Margin

0.00%

Return On Equity TTM

-96.20%

Acumen Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Acumen Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Acumen Pharmaceuticals Inc image
Acumen Pharmaceuticals Inc
BUY$171.9MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.8B125.53%74.6712.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.3B101.66%27.732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.0BNA118.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B42.22%17.1229.65%

Stock Returns calculator for Acumen Pharmaceuticals Inc Stock including INR - Dollar returns

The Acumen Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Acumen Pharmaceuticals Inc investment value today

Current value as on today

₹2,85,972

Returns

₹1,85,972

(+185.97%)

Returns from Acumen Pharmaceuticals Inc Stock

₹1,53,000 (+153%)

Dollar Impact

₹32,972 (+32.97%)

Analyst Recommendation on Acumen Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Acumen Pharmaceuticals Inc. Average target price of $7.4

Acumen Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Acumen Pharmaceuticals Inc.

What analysts predicted

65.81%UPSIDE

Target Price

$7.4

Current Price

$2.53

Analyzed by

12 Analysts

Target

$7.40

Acumen Pharmaceuticals Inc target price $7.4, a slight upside of 65.81% compared to current price of $2.53. According to 12 analysts rating.

Acumen Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Acumen Pharmaceuticals Inc Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-3% versus previous 30 day period

Acumen Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
-
0
Operating Income
-16
-18
-17
-24
-32
-39
-30
-41
-26
-25
EBITDA
-16
-15
-13
-19
-28
-36
-27
-39
-25
-25
Interest Expense
-
0
1
1
1
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-16
-14
-20
-29
-37
-28
-40
-26
-25
Income Tax Expense
0
3
0
-
-
0
-
-
-
-
Net Income
-12
-16
-14
-20
-29
-37
-28
-40
-26
-25
Net Profit Margin
0.00%
-5688.62%
0.00%
0.00%
0.00%
-20873.03%
0.00%
0.00%
0.00%
0.00%

Acumen Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
1
-
-
-
-
Gross Profit
-6
-6
-12
0
-42
0
0
Operating Income
-7
-7
-19
-45
-61
-114
-123
EBITDA
0
-7
-19
-42
-51
-98
-123
Interest Expense
-
-
81
2
0
4
4
Depreciation
-
-
0
0
0
0
0
Income Before Tax
-7
-7
-100
-42
-52
-102
-121
Income Tax Expense
0
0
81
-2
-
-
-
Net Income
-7
-7
-100
-42
-52
-102
-121
Net Profit Margin
-465.94%
-510.10%
-7005.99%
0.00%
0.00%
0.00%
0.00%

Acumen Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-16
-14
-20
-29
-37
-28
-40
-26
-25
Operating Cash Flow
-8
-17
-16
-24
-27
-34
-31
-30
-19
Investing Cash Flow
-48
-9
37
-10
29
28
38
40
26
Financing Cash Flow
29
7
0
0
0
0
-
-
0
Change in Cash
-27
-19
21
-34
2
-5
6
10
7

Acumen Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-100
-42
-52
-102
-121
Operating Cash Flow
-7
-17
-35
-43
-86
-115
Investing Cash Flow
-104
-104
39
-171
48
133
Financing Cash Flow
44
200
3
151
6
0
Change in Cash
37
78
7
-62
-31
18

Global Institutional Holdings in Acumen Pharmaceuticals Inc

Funds
Holdings
RA Capital Management, LLC
20.67%
LAURION CAPITAL MANAGEMENT LP
1.43%
Renaissance Technologies Corp
0.59%
Knollwood Investment Advisory LLC
2.25%
Ikarian Capital, LLC
0.44%
See all

Insights on Acumen Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABOS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ABOS stock has moved up by 148.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ACUMEN PHARMACEUTICALS INC has experienced a drawdown of -53.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 46.2%

About Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug, as well as with JCR Pharmaceuticals Co. Ltd for the development of Aß oligomer-targeted enhanced brain delivery therapy for the treatment of Alzheimer's disease. The company was incorporated in 1996 and is headquartered in Newton, Massachusetts.
OrganisationAcumen Pharmaceuticals Inc
Headquarters1210-1220 Washington St., Newton, MA, United States, 02465
IndustryBiotechnology
CEOMr. Daniel J. O'Connell M.B.A.
E-voting on sharesClick here to vote

Key Management of Acumen Pharmaceuticals Inc

Name

Title

Mr. Matt Zuga

CFO & Chief Business Officer

Dr. William L. Klein Ph.D.

Co-Founder

Ms. Kelly Carranza

Senior Vice President of Finance & Accounting and Corporate Controller

Ms. Alex Braun M.B.A.

VP & Head of Investor Relations

Mr. Derek M. Meisner Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Daniel J. O'Connell M.B.A.

CEO & Director

Dr. James Doherty Ph.D.

President & Chief Development Officer

Dr. Grant A. Krafft Ph.D.

Co-Founder

Dr. Caleb E. Finch Ph.D.

Co-Founder

Mr. Russell Barton M.S.

Chief Operating Officer

FAQs

What is Acumen Pharmaceuticals Inc share price today?

Acumen Pharmaceuticals Inc share price today is $2.53 as on at the close of the market. Acumen Pharmaceuticals Inc share today touched a day high of $2.55 and a low of $2.47.

What is the 52 week high and 52 week low for Acumen Pharmaceuticals Inc share?

Acumen Pharmaceuticals Inc share touched a 52 week high of $3.6 on and a 52 week low of $0.96 on . Acumen Pharmaceuticals Inc stock price today i.e. is closed at $2.53,which is 29.72% down from its 52 week high and 163.93% up from its 52 week low.

What is Acumen Pharmaceuticals Inc's market capitalisation today?

Acumen Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Acumen Pharmaceuticals Inc Stock (ABOS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Acumen Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acumen Pharmaceuticals Inc Shares that will get you 0.5929 shares as per Acumen Pharmaceuticals Inc share price of $2.53 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Acumen Pharmaceuticals Inc Stock (ABOS) from India?

Indian investors can start investing in Acumen Pharmaceuticals Inc (ABOS) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Acumen Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Acumen Pharmaceuticals Inc share’s latest price of $2.53 as on May 6, 2026 at 1:29 am IST, you will get 3.9526 shares of Acumen Pharmaceuticals Inc. Learn more about fractional shares .